Anfield Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7K | Hold |
79
| – | – | ﹤0.01% | 247 |
|
|
2025
Q1 | $16.6K | Hold |
79
| – | – | 0.01% | 202 |
|
|
2024
Q4 | $14K | Hold |
79
| – | – | 0.01% | 205 |
|
|
2024
Q3 | $15.6K | Hold |
79
| – | – | 0.01% | 188 |
|
|
2024
Q2 | $13.6K | Buy |
+79
| New | +$13.6K | 0.01% | 163 |
|
|
2023
Q1 | – | Sell |
-1,076
| Closed | -$174K | – | 70 |
|
|
2022
Q4 | $174K | Sell |
1,076
-879
| -45% | -$142K | 0.09% | 66 |
|
|
2022
Q3 | $262K | Buy |
1,955
+67
| +4% | +$8.98K | 0.12% | 66 |
|
|
2022
Q2 | $289K | Sell |
1,888
-1,123
| -37% | -$172K | 0.13% | 64 |
|
|
2022
Q1 | $488K | Buy |
+3,011
| New | +$488K | 0.18% | 54 |
|
|
2021
Q3 | – | Sell |
-110
| Closed | -$12K | – | 127 |
|
|
2021
Q2 | $12K | Buy |
+110
| New | +$12K | ﹤0.01% | 156 |
|
|
2020
Q1 | – | Sell |
-1,871
| Closed | -$162K | – | 102 |
|
|
2019
Q4 | $162K | Buy |
+1,871
| New | +$162K | 0.07% | 133 |
|